Royalty Pharma plc (RPRX)

Royalty Pharma Revenue

Royalty Pharma had revenue of $630.58M in the quarter ending March 31, 2026, with 10.97% growth. This brings the company's revenue in the last twelve months to $2.44B, up 7.80% year-over-year. In the year 2025, Royalty Pharma had annual revenue of $2.38B with 5.06% growth.

• Revenue (ttm): $2.44B
• Revenue Growth: +7.80%
• P/S Ratio: 13.16
• Revenue / Employee: $24,405,220
• Employees: 100
• Market Cap: 32.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.38B	114.61M	5.06%
Dec 31, 2024	2.26B	-90.97M	-3.86%
Dec 31, 2023	2.35B	117.33M	5.24%
Dec 31, 2022	2.24B	-52.24M	-2.28%
Dec 31, 2021	2.29B	167.11M	7.87%
Dec 31, 2020	2.12B	308.10M	16.98%
Dec 31, 2019	1.81B	19.36M	1.08%
Dec 31, 2018	1.79B	196.96M	12.33%
Dec 31, 2017	1.60B	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error